Suspicious cold thyroid nodule with intense focal 68Ga-DOTATATE uptake: a case report.

Autor: Manta R; Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. ringo.manta@ulb.be., Delbart W; Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium., Duran Derijckere I; Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium., Quiriny M; Surgical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium., Demetter P; Pathology Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium., Flamen P; Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium., Karfis I; Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Publikováno v: European journal of hybrid imaging [Eur J Hybrid Imaging] 2022 Apr 19; Vol. 6 (1), pp. 8. Date of Electronic Publication: 2022 Apr 19.

Clinico-metabolic characterization improves the prognostic value of histological growth patterns in patients undergoing surgery for colorectal liver metastases.

Autor: Bohlok A; Department of Surgical Oncology, Jules Bordet Institute, Free University of Brussels (ULB), Brussels, Belgium., Duran Derijckere I; Department of Nuclear Medicine, Jules Bordet Institute, Free University of Brussels (ULB), Brussels, Belgium., Azema H; Department of Surgical Oncology, Jules Bordet Institute, Free University of Brussels (ULB), Brussels, Belgium., Lucidi V; Department of Abdominal Surgery, Erasme Hospital, Free University of Brussels (ULB), Brussels, Belgium., Vankerckhove S; Department of Surgical Oncology, Jules Bordet Institute, Free University of Brussels (ULB), Brussels, Belgium., Hendlisz A; Department of Digestive Oncology, Jules Bordet Institute, Free University of Brussels (ULB), Brussels, Belgium., Van Laethem JL; Department of Hepato-Gastroenterology, Erasme Hospital, Free University of Brussels (ULB), Brussels, Belgium., Vierasu I; Department of Nuclear Medicine, Erasme Hospital, Free University of Brussels (ULB), Brussels, Belgium., Goldman S; Department of Nuclear Medicine, Erasme Hospital, Free University of Brussels (ULB), Brussels, Belgium., Flamen P; Department of Nuclear Medicine, Jules Bordet Institute, Free University of Brussels (ULB), Brussels, Belgium., Larsimont D; Department of Pathology, Jules Bordet Institute, Free University of Brussels (ULB), Brussels, Belgium., Demetter P; Department of Pathology, Jules Bordet Institute, Free University of Brussels (ULB), Brussels, Belgium., Dirix L; Translational Cancer Research Unit (CORE), Gasthuiszusters Antwerpen Hospitals, University of Antwerp, Antwerp, Belgium., Vermeulen P; Translational Cancer Research Unit, GZA Hospitals & CORE, MIPRO, University of Antwerp, Antwerp, Belgium., Donckier V; Department of Surgical Oncology, Jules Bordet Institute, Free University of Brussels (ULB), Brussels, Belgium.

Publikováno v: Journal of surgical oncology [J Surg Oncol] 2021 May; Vol. 123 (8), pp. 1773-1783. Date of Electronic Publication: 2021 Mar 22.

Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study.

Autor: Levillain H; Nuclear Medicine Department, Jules Bordet Institute, Université Libre de Bruxelles, 1 rue Héger-Bordet, 1000, Brussels, Belgium. hugo.levillain@bordet.be., Duran Derijckere I; Nuclear Medicine Department, Jules Bordet Institute, Université Libre de Bruxelles, 1 rue Héger-Bordet, 1000, Brussels, Belgium., Ameye L; Data Center Department, Jules Bordet Institute, Université Libre de Bruxelles, 1 rue Héger-Bordet, 1000, Brussels, Belgium., Guiot T; Medical Physics Department, Jules Bordet Institute, Université Libre de Bruxelles, 1 rue Héger-Bordet, 1000, Brussels, Belgium., Braat A; Radiology and Nuclear Medicine Department, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands., Meyer C; Radiology Department, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127, Bonn, Germany., Vanderlinden B; Medical Physics Department, Jules Bordet Institute, Université Libre de Bruxelles, 1 rue Héger-Bordet, 1000, Brussels, Belgium., Reynaert N; Medical Physics Department, Jules Bordet Institute, Université Libre de Bruxelles, 1 rue Héger-Bordet, 1000, Brussels, Belgium., Hendlisz A; Digestive Oncology Department, Jules Bordet Institute, Université Libre de Bruxelles, 1 rue Héger-Bordet, 1000, Brussels, Belgium., Lam M; Radiology and Nuclear Medicine Department, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands., Deroose CM; Department of Imaging and Pathology, Nuclear Medicine, University Hospitals Leuven and Nuclear Medicine and Molecular Imaging, KU Leuven, Herestraat 49, 3000, Leuven, Belgium., Ahmadzadehfar H; Nuclear Medicine Department, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127, Bonn, Germany., Flamen P; Nuclear Medicine Department, Jules Bordet Institute, Université Libre de Bruxelles, 1 rue Héger-Bordet, 1000, Brussels, Belgium.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2019 Oct; Vol. 46 (11), pp. 2270-2279. Date of Electronic Publication: 2019 Jul 19.

⁹⁰ Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer.

Autor: Levillain H; Department of Nuclear Medicine, Jules Bordet Institute, Université Libre de Bruxelles, Rue Héger-Bordet 1, B-1000, Brussels, Belgium. hugo.levillain@bordet.be., Duran Derijckere I; Department of Nuclear Medicine, Jules Bordet Institute, Université Libre de Bruxelles, Rue Héger-Bordet 1, B-1000, Brussels, Belgium., Marin G; Department of Medical Physics, Jules Bordet Institute, Université Libre de Bruxelles, Rue Héger-Bordet 1, B-1000, Brussels, Belgium., Guiot T; Department of Nuclear Medicine, Jules Bordet Institute, Université Libre de Bruxelles, Rue Héger-Bordet 1, B-1000, Brussels, Belgium., Vouche M; Department of Radiology, Hôpital St-Pierre, Jules Bordet Institute, Université Libre de Bruxelles, Rue Héger-Bordet 1, B-1000, Brussels, Belgium., Reynaert N; Department of Medical Physics, Jules Bordet Institute, Université Libre de Bruxelles, Rue Héger-Bordet 1, B-1000, Brussels, Belgium., Hendlisz A; Department of Digestive Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Rue Héger-Bordet 1, B-1000, Brussels, Belgium., Vanderlinden B; Department of Medical Physics, Jules Bordet Institute, Université Libre de Bruxelles, Rue Héger-Bordet 1, B-1000, Brussels, Belgium., Flamen P; Department of Nuclear Medicine, Jules Bordet Institute, Université Libre de Bruxelles, Rue Héger-Bordet 1, B-1000, Brussels, Belgium.

Publikováno v: EJNMMI research [EJNMMI Res] 2018 Jul 13; Vol. 8 (1), pp. 60. Date of Electronic Publication: 2018 Jul 13.

Interventional Radiology Locoregional Therapies for Intrahepatic Cholangiocarcinoma.

Autor: Woodhead, Gregory¹ (AUTHOR) gregorywoodhead@radiology.arizona.edu, Lee, Sean² (AUTHOR) slee55@student.touro.edu, Struycken, Lucas¹ (AUTHOR) dgoldberg@radiology.arizona.edu, Goldberg, Daniel¹ (AUTHOR) jackh@arizona.edu, Hannallah, Jack¹ (AUTHOR) shamar@arizona.edu, Young, Shamar¹ (AUTHOR)

Publikováno v: Life (2075-1729). Feb2024, Vol. 14 Issue 2, p217. 14p.